Trial Profile
Multicenter, open-label, randomised, haloperidol-controlled study to evaluate Seroquel [quetiapine] as mono-therapy in the treatment of agitated symptoms in the patients with acute episode of schizophrenia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2012
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Haloperidol
- Indications Schizophrenia
- Focus Therapeutic Use
- 21 Aug 2012 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 02 Apr 2008 New trial record.